Abstract:
This invention generally relates to biomarkers useful in the treatment of IL-23 related diseases, in particular inflammatory diseases such as psoriasis. The invention also relates to methods of using the biomarkers disclosed herein, for example in therapies utilizing IL-23 antagonists.
Abstract:
The present invention relates to antibody molecules against anticoagulants, in particular dabigatran, and their use as antidotes of such anticoagulants.
Abstract:
Disclosed are porous polymer/carrier solid phase reactants which consist of a polymer that consists of fine particles and is situated in the pore space of porous carrier materials. Reactive groups are bound to the polymer. Said groups act as reactants in organic-chemical syntheses. Said solid phase reactants can be produced as bulk material or tubes, plates or rods, can be built in pressure sealed housings and can be used in flow-through apparatuses or microtitration fields for the synthesis of organic products. Potential active agents can be produced at high speed by using the inventive porous polymer/carrier solid phase reactants that can be flown through convectively, whereby production requires only little isolation and cleaning.
Abstract:
Disclosed is a method carried out in a reaction column for chemically reacting substances whose reaction is limited by an unfavourable equilibrium position of the formation reaction or by a preceding equilibrium. During the reaction, one or more auxiliary substances acting as permanent gases such as a stripping gas are used to remove one or more substances from the reaction mixture.
Abstract:
A chemical process for treating an alcohol-containing mixture is coupled to a rightening reaction that converts during the process the alcohol contained in the mixture into tertiary butylether by reaction with a C4 fraction in the presence of an acid catalyst. This process is preferably used for direct methane oxidation into methanol, during which methanol is converted into MTBE.
Abstract:
The present invention relates to antibody molecules against anticoagulants, in particular dabigatran, and their use as antidotes of such anticoagulants.
Abstract:
An improved process for the hydration of C2-C5 olefins to the corresponding alcohols via heterogeneous reactive extraction with ion exchange resin catalysts is provided. The improvements are based on the application of a structured catalytic packing, a simultaneous product extraction in multiple condensed phases for enhancement of the overall alcohol production rate and a simplified product purification procedure.
Abstract:
Die vorliegende Erfindung betrifft einen Brückenzünder (1), der eine Widerstandsschicht (3) mit einem vorbestimnten elektrischen Widerstand, die durch einen elektrischen Strom erwärmbar ist; eine elektrische Isolationsschicht (4), die auf der Widerstandsschicht (3) angeordnet ist und eine vorbestimmte Wärmeleitfähigkeit aufweist; eine Reaktivschicht, die auf der Isolationsschicht angeordnet ist, wobei die Isolationsschicht (4) die in der Widerstandsschicht (3) erzeugte Wärme an die Reaktivschicht (5) überträgt, wodurch diese exotherm reagiert; und eine pyrotechnische Schicht (7) aufweist, die auf oder oberhalb der Reaktivschicht (5) angeordnet und durch die exotherme Reaktion der Reaktivschicht (5) initiierbar ist.
Abstract:
The invention pertains to a support catalyst in the form of fillers, constructed from an open-pore support material on whose outer and inner surfaces a macroporous ion exchange resin is mechanically and/or chemically affixed.
Abstract:
An improved process for the hydration of C 2 -C 5 olefins to the corresponding alcohols via heterogeneous reactive extraction with ion exchange resin catalysts is provided. The improvements are based on the application of a structured catalytic packing, a simultaneous product extraction in multiple condensed phases for enhancement of the overall alcohol production rate and a simplified product purification procedure.